Search

everythinglearnresearchcommunity

for

Search:↓

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Hair follicles are smaller in people with androgenetic alopecia compared to those with normal scalps.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Injecting vitamin D3 into the skin is an effective treatment for patchy hair loss.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

A woman with a rare scalp condition causing a thick scalp and hair loss didn't improve with steroid treatment.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

Tofacitinib is an effective and safe treatment for alopecia areata.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

The text talks about a rare skin condition causing hair loss and suggests that people with this should also check their lung and heart health.